2 Alzheimer’s Drugs Found Ineffective in Clinical Trials
Dashing hopes, bapineuzumab and solanezumab did not improve patients’ ability to think or perform daily activitiesContinue Reading
Dashing hopes, bapineuzumab and solanezumab did not improve patients’ ability to think or perform daily activitiesContinue Reading
They include poorly organized trials and no follow-up on side effects from the medicines testedContinue Reading
Better communication with their doctors might improve outcomes, researchers sayContinue Reading
Scan tracks entire genome from a blood sampleContinue Reading
More study needed, but researchers suspect benefit may be due to reduced inflammationContinue Reading
Study supports asking a simple question, rather than giving lengthy questionnaireContinue Reading
Don’t use flammable products near candles, hair appliances, agency saysContinue Reading
Expert says providing support, treatment could help prevent needless deaths in this high-risk groupContinue Reading
But larger, longer trials are needed, experts sayContinue Reading
Many aren’t comfortable writing the prescription and most would refer patient to a psychiatrist, study findsContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.